Julius Knowles - Net Worth and Insider Trading
Julius Knowles Net Worth
The estimated net worth of Julius Knowles is at least $40 Million dollars as of 2024-11-13. Julius Knowles is the Director of Keros Therapeutics Inc and owns about 621,952 shares of Keros Therapeutics Inc (KROS) stock worth over $40 Million. Details can be seen in Julius Knowles's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Julius Knowles has not made any transactions after 2021-12-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Julius Knowles
Julius Knowles Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Julius Knowles owns 1 companies in total, including Keros Therapeutics Inc (KROS) .
Click here to see the complete history of Julius Knowles’s form 4 insider trades.
Insider Ownership Summary of Julius Knowles
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KROS | Keros Therapeutics Inc | 2021-12-02 | director |
Julius Knowles Latest Holdings Summary
Julius Knowles currently owns a total of 1 stock. Julius Knowles owns 621,952 shares of Keros Therapeutics Inc (KROS) as of December 2, 2021, with a value of $40 Million.
Latest Holdings of Julius Knowles
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KROS | Keros Therapeutics Inc | 2021-12-02 | 621,952 | 64.80 | 40,302,490 |
Holding Weightings of Julius Knowles
Julius Knowles Form 4 Trading Tracker
According to the SEC Form 4 filings, Julius Knowles has made a total of 15 transactions in Keros Therapeutics Inc (KROS) over the past 5 years, including 1 buys and 14 sells. The most-recent trade in Keros Therapeutics Inc is the sale of 47,651 shares on December 2, 2021, which brought Julius Knowles around $3 Million.
Insider Trading History of Julius Knowles
- 1
Julius Knowles Trading Performance
GuruFocus tracks the stock performance after each of Julius Knowles's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Julius Knowles is 32.59%. GuruFocus also compares Julius Knowles's trading performance to market benchmark return within the same time period. The performance of stocks bought by Julius Knowles within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Julius Knowles's insider trading performs compared to the benchmark.
Performance of Julius Knowles
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.76 | | | | | |
| Relative Return to S&P 500(%) | 21.65 | | | | | |
Julius Knowles Ownership Network
Ownership Network List of Julius Knowles
Ownership Network Relation of Julius Knowles
Julius Knowles Owned Company Details
What does Keros Therapeutics Inc do?
Who are the key executives at Keros Therapeutics Inc?
Julius Knowles is the director of Keros Therapeutics Inc. Other key executives at Keros Therapeutics Inc include Chief Financial Officer Keith Regnante , Chief Scientific Officer Jennifer Lachey , and Chief Operating Officer Christopher Rovaldi .
Keros Therapeutics Inc (KROS) Insider Trades Summary
Over the past 18 months, Julius Knowles made no insider transaction in Keros Therapeutics Inc (KROS). Other recent insider transactions involving Keros Therapeutics Inc (KROS) include a net sale of 80,000 shares made by Keith Regnante , a net sale of 250,000 shares made by Orbimed Advisors Llc , and a net sale of 250,000 shares made by Carl L Gordon .
In summary, during the past 3 months, insiders sold 0 shares of Keros Therapeutics Inc (KROS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 580,000 shares of Keros Therapeutics Inc (KROS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 580,000 shares.
Keros Therapeutics Inc (KROS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Keros Therapeutics Inc Insider Transactions
Julius Knowles Mailing Address
Above is the net worth, insider trading, and ownership report for Julius Knowles. You might contact Julius Knowles via mailing address: C/o Keros Therapeutics, Inc., 99 Hayden Avenue, Suite 120, Building E, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
